RxDoctor Payments DataLook up a doctor →

Prachi Patel, DO

Family Practice · la Grange, ILNPI 1144545849

Payments from drug & device makers

$11,840in general payments, 2019–2025

Across 638 payments — averaging $18.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Boehringer Ingelheim$1K
  • AstraZeneca$1K
  • Novo Nordisk$994
  • GSK$917
  • Lilly USA, LLC$732
  • plus $5K from 46 others

What the payments were for

  • Food & beverage$11,840100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,840 in reported general payments places this provider in the 95th percentile of 668 family practice providers in Illinois.

See all family practice providers in Illinois

Medicare billing

Part B allowed, 2024
$108,360
Medicare patients
344
Services billed
1,228

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide47$49,727
EliquisApixaban48$42,598
RybelsusSemaglutide14$22,372
EntrestoSacubitril/Valsartan20$22,107
XareltoRivaroxaban21$22,040
ProliaDenosumab11$18,983
JardianceEmpagliflozin12$18,847
Trelegy ElliptaFluticasone/Umeclidin/Vilanter21$16,183
Levothyroxine Sodium311$3,465
Atorvastatin Calcium302$2,549
Metoprolol Succinate113$1,815
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen66$1,691
Albuterol Sulfate HfaAlbuterol Sulfate52$1,606
SynthroidLevothyroxine Sodium22$1,433
Rosuvastatin Calcium107$1,364

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$732$49,72747 claims
PfizerEliquis$419$42,59848 claims
Novo NordiskRybelsus$994$22,37214 claims
Johnson & JohnsonXarelto$51$22,04021 claims
AmgenProlia$635$18,98311 claims
Boehringer IngelheimJardiance$1,372$18,84712 claims
GSKTrelegy Ellipta$917$16,18321 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$46$3,465311 claims
AbbVieSynthroid$1,883$1,43322 claims
Almatica Pharma LLCSertraline Hcl$80$64577 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 668 family practice providers in Illinois.

Other family practice in la Grange

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →